Prescription for Pediatric Asthma Exacerbation
For a child with asthma exacerbation, prescribe: albuterol MDI 4-8 puffs every 20 minutes for up to 3 hours (with spacer and face mask if <4 years), oral prednisolone 1-2 mg/kg/day (maximum 60 mg/day) for 3-10 days, and initiate a daily inhaled corticosteroid at any point during treatment. 1, 2
Rescue Inhaler (Acute Treatment)
Albuterol (SABA) is the first-line bronchodilator:
- MDI dosing: 4-8 puffs every 20 minutes as needed for up to 3 hours 1, 2
- Must use with valved holding chamber (spacer) and face mask for children <4 years
- After initial stabilization, continue every 2-6 hours as needed
Add ipratropium bromide for severe exacerbations only:
- Combined albuterol/ipratropium MDI: 4-8 puffs every 20 minutes for up to 3 hours 1
- Should NOT be used as first-line therapy
- No additional benefit once hospitalized, so discontinue if admitted
Oral Corticosteroids
Prednisolone dosing (preferred oral formulation in children):
- 1-2 mg/kg/day in 2 divided doses, maximum 60 mg/day 1, 2
- Duration: 3-10 days until symptoms resolve or peak flow reaches 70% predicted
- No taper needed for courses ≤10 days, especially if concurrent ICS use 1, 2
Key Evidence Points:
- Recent high-quality evidence shows 1 mg/kg/day is non-inferior to 2 mg/kg/day for moderate exacerbations, with significantly less vomiting 3
- For moderate exacerbations, consider the lower dose (1 mg/kg/day) to reduce side effects
- For severe exacerbations, use the full 2 mg/kg/day dose
- Oral route is always preferred over IV in pediatrics—no advantage to IV administration if GI absorption intact 1, 2
Daily Inhaled Corticosteroid (Controller)
ICS can and should be started at any point during the exacerbation 1, 2:
- Do not wait for exacerbation to resolve
- This is critical for long-term control and preventing future exacerbations
Important caveat: While some older studies suggested high-dose inhaled budesonide might substitute for oral steroids 4, systemic oral corticosteroids remain superior for acute exacerbations and produce better outcomes including earlier discharge and fewer relapses 5. The evidence does not support using inhaled corticosteroids as equivalent to oral steroids during acute exacerbations 6, 5.
Common Pitfalls to Avoid:
- Don't use ipratropium as monotherapy—always combine with albuterol for severe cases only
- Don't taper short steroid courses—unnecessary for ≤10 days and increases complexity/non-adherence
- Don't delay starting maintenance ICS—can begin immediately during exacerbation
- Don't prescribe IV steroids routinely—oral route equally effective and preferred in children
- Don't increase maintenance ICS dose during exacerbations—evidence shows this strategy does not reduce need for rescue oral steroids 7